Fundraising Fox

Nference

Cambridge, US · 2 known investors

nference.ai ↗
Biotechin /nference

Founders & leadership

TM
Thomas McNaughtonExecutive Officer
VS
Venkataramanan SoundararajanExecutive Officer
MA
Murali AravamudanExecutive Officer, Director
JH
John HalamkaDirector
DG
David GoelDirector
AR
Ajit RajasekharanExecutive Officer

Investors · 2

NTT Venture CapitalMenlo Park
Matrix PartnersreportedSan Francisco · $100K – $10Mvia Tim Barrows · board

Reported raises · per SEC filings

Form D private placements
▶$2.7MraisedNov 2022 · 72 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Thomas McNaughtonExecutive Officer
  • Venkataramanan SoundararajanExecutive Officer
  • Murali AravamudanExecutive Officer, Director
  • John HalamkaDirector
  • David GoelDirector
  • Ajit RajasekharanExecutive Officer
Offering amount
$2.7M
Amount sold
$2.7M
First sale
Oct 2022
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$9.6MraisedMar 2020 · 57 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Murali AravamudanExecutive Officer, Director
  • Venkataramanan SoundararajanExecutive Officer
  • Harris FishmanExecutive Officer
  • Agustin MarquezExecutive Officer
  • Andrew DanielsenDirector
  • David GoelDirector
  • Ajit RajasekharanExecutive Officer
  • Tim BarrowsDirector
Offering amount
$9.6M
Amount sold
$9.6M
First sale
Mar 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Nference — Investors & Founders | Fundraising Fox